Biokeralty will be attending NanoMed Europe 2025 (NME25), the main European forum on nanotechnology in healthcare, which brings together experts, researchers and key organisations in the sector.

On behalf of Biokeralty, Ángel del Pozo, our Deputy Programme Strategy Manager, who is part of the Scientific Committee of the event, will participate on 28 May in a session focused on European nanomedicine projects. During his intervention, he will present the IN-ARMOR project (Therapeutic Epigenetic Enhancement of Innate Immunity to Effectively Combat Antimicrobial Resistance).

This ambitious European project aims to develop new therapeutic strategies based on epigenetics in order to enhance innate immunity and effectively combat antimicrobial resistance, one of the biggest challenges in healthcare currently.

Participation in NME25 reinforces Biokeralty’s commitment to nanotechnology as a key strategic line, and highlights our ability to lead innovative initiatives at a European level, collaborating with leading scientific and technological partners.

For more information about the event, visit NanoMed Europe 2025 and learn more about the IN-ARMOR project.